Leicester’s hospitals welcomed 20 people who have recently migrated to the UK to visit this week for an informative and practical clinical research open day.
Leicester’s BRC & CRF were pleased to welcome the Director of Science, Research and Evidence at the Department of Health and Social Care (DHSC) and Deputy CEO of the National Institute for Health and Care Research (NIHR) Dr Gail Marzetti, and Dr Natalie Owen, Head of Infrastructure at the DSHC, on Monday 23 October.
Leicester’s Clinical Research Facility has welcomed its first ever student nurse for a pilot four-week work placement as part of a collaboration with the University of Leicester.
Navneet Ghuman, part of NIHR Leicester’s Clinical Research Facility team, was one of several staff members recognized for their outstanding contributions to work at the Intensive Care Therapy Unit as the NIHR Leicester Biomedical Research Centre’s Respiratory Theme crowned their Research Champions.
In July we welcomed Delores Kannas (pictured above third from the right), a visiting nurse from Seattle Washington, who was taking part in the training exchange programme.
UKCRF Network awarded £2.4 million in public funding to support the delivery of early phase research studies
The UK Clinical Research Facility Network (UKCRF Network), hosted by Manchester University NHS Foundation Trust (MFT), has been awarded £2.4 million funding by the National Institute for Health and Care Research (NIHR) to support research studies over the next five years.
Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows study ran in the East Midlands
COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.
Local health researchers are celebrating after it was announced that the National Institute for Health Research (NIHR) Leicester Clinical Research Facility (CRF) based at University Hospitals of Leicester (UHL) NHS Trust has been awarded £4.1 million over the next five years to carry out early phase clinical research.